FI964318A0 - Uusia kinoloni-5-(N-heterosubstituoitu amino)-antimikrobisia aineita - Google Patents

Uusia kinoloni-5-(N-heterosubstituoitu amino)-antimikrobisia aineita

Info

Publication number
FI964318A0
FI964318A0 FI964318A FI964318A FI964318A0 FI 964318 A0 FI964318 A0 FI 964318A0 FI 964318 A FI964318 A FI 964318A FI 964318 A FI964318 A FI 964318A FI 964318 A0 FI964318 A0 FI 964318A0
Authority
FI
Finland
Prior art keywords
antimicrobial agents
new quinolone
heterosubstituted amino
heterosubstituted
amino
Prior art date
Application number
FI964318A
Other languages
English (en)
Swedish (sv)
Other versions
FI964318A (fi
Inventor
Jr Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI964318A0 publication Critical patent/FI964318A0/fi
Publication of FI964318A publication Critical patent/FI964318A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI964318A 1994-04-28 1996-10-25 Uusia kinoloni-5-(N-heterosubstituoitu amino)-antimikrobisia aineita FI964318A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/235,003 US5646163A (en) 1992-10-30 1994-04-28 Quinolone 5-(N-heterosubstituted amino) antimicrobials
PCT/US1995/004495 WO1995029894A1 (en) 1994-04-28 1995-04-11 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials

Publications (2)

Publication Number Publication Date
FI964318A0 true FI964318A0 (fi) 1996-10-25
FI964318A FI964318A (fi) 1996-12-23

Family

ID=22883653

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964318A FI964318A (fi) 1994-04-28 1996-10-25 Uusia kinoloni-5-(N-heterosubstituoitu amino)-antimikrobisia aineita

Country Status (11)

Country Link
US (1) US5646163A (fi)
EP (1) EP0757675A1 (fi)
JP (1) JPH09512549A (fi)
KR (1) KR100244992B1 (fi)
CN (1) CN1157611A (fi)
AU (1) AU2246695A (fi)
BR (1) BR9507553A (fi)
CA (1) CA2188918A1 (fi)
FI (1) FI964318A (fi)
NO (1) NO964533L (fi)
WO (1) WO1995029894A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1650203E (pt) * 2000-09-11 2008-05-13 Novartis Vaccines & Diagnostic Processo de preparação de derivados de benzimidazol-2-ilquinolinona
CN1867570A (zh) * 2003-08-12 2006-11-22 艾其林医药公司 作为抗感染试剂的异噻唑喹诺酮及其相关化合物
WO2005026147A1 (ja) * 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
CA2576530A1 (en) * 2004-08-11 2006-02-23 Donald L. Barbeau Noncardiotoxic pharmaceutical compounds
EP1776109B1 (en) * 2004-08-13 2008-12-31 Schering-Plough Ltd. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
CA2580749C (en) * 2004-09-17 2014-01-28 Cylene Pharmaceuticals, Inc. Quinolone analogs
WO2006118605A2 (en) * 2004-11-11 2006-11-09 Achillion Pharmaceuticals, Inc. 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
WO2006074317A1 (en) * 2005-01-05 2006-07-13 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents
US7199128B2 (en) 2005-02-02 2007-04-03 Achillion Pharmaceuticals, Inc. 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
EA200701734A1 (ru) * 2005-02-16 2008-02-28 Ачиллион Фармасьютикалз, Инк. Новые изотиазолохинолоны и родственные им соединения как антиинфекционные средства
EP1913004B1 (en) 2005-07-27 2010-09-22 Achillion Pharmaceuticals, Inc. 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
US7816524B2 (en) * 2005-08-05 2010-10-19 Cylene Pharmaceuticals, Inc. Methods of preparing quinolone analogs
CL2007003332A1 (es) * 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US8183236B2 (en) * 2007-04-12 2012-05-22 University Of Southern California Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
US8222407B2 (en) * 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EA201101451A1 (ru) * 2009-04-03 2012-03-30 Ачиллион Фармасьютикалз, Инк. Гидрокситиенохинолоны и родственные соединения как противоинфекционные средства
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
CA2777741A1 (en) 2009-10-16 2011-04-21 Rib-X Pharmaceuticals, Inc. Antimicrobial compounds and methods of making and using the same
SG10201406635QA (en) * 2009-10-16 2014-11-27 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
CN102712657A (zh) 2009-10-16 2012-10-03 Rib-X制药公司 抗微生物化合物和其制备和使用方法
JP2016529325A (ja) 2013-09-09 2016-09-23 メリンタ セラピューティクス，インコーポレイテッド 抗微生物化合物ならびにそれの製造方法および使用方法
JP2016536338A (ja) 2013-09-09 2016-11-24 メリンタ セラピューティクス，インコーポレイテッド 抗微生物化合物ならびにそれの製造方法および使用方法
CA2979342A1 (en) 2015-03-11 2016-09-15 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
CA3023317A1 (en) 2016-05-06 2017-11-09 Melinta Therapeutics, Inc. Antimicrobials and methods of making and using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4954507A (en) * 1986-10-08 1990-09-04 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2664950B2 (ja) * 1988-08-31 1997-10-22 日本電気株式会社 入出力処理装置
US4945160A (en) * 1988-11-22 1990-07-31 Warner-Lambert Company Preparation of certain 7-substituted quinolones
JPH05506033A (ja) * 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 抗微生物性キノロニルラクタム類
HUT67423A (en) * 1991-10-01 1995-04-28 Procter & Gamble Pharma Process for the production of antimicrobal compounds containing quinolone moiety and beta-lactam moiety
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Also Published As

Publication number Publication date
AU2246695A (en) 1995-11-29
KR100244992B1 (ko) 2000-03-02
KR970702849A (ko) 1997-06-10
CN1157611A (zh) 1997-08-20
JPH09512549A (ja) 1997-12-16
BR9507553A (pt) 1997-08-05
NO964533D0 (no) 1996-10-25
FI964318A (fi) 1996-12-23
NO964533L (no) 1996-12-23
EP0757675A1 (en) 1997-02-12
US5646163A (en) 1997-07-08
CA2188918A1 (en) 1995-11-09
WO1995029894A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
FI964318A0 (fi) Uusia kinoloni-5-(N-heterosubstituoitu amino)-antimikrobisia aineita
DE69534990D1 (de) Kontrastmittel
DK0745089T3 (da) Antiparasitiske midler
NO985643D0 (no) Antimikrobielle blandinger
NO981133D0 (no) Ikke-reseptormedierte kontrastmidler
NO304430B1 (no) Antifungale midler
NO985294D0 (no) Kontrastmidler
NO20000125D0 (no) Tiadiazolyl- og oksadiazolylfenyloksazolidinon- antibakterielle midler
BR9408582A (pt) Composição herbicida
DE69621528D1 (de) Anti-inflamatorische agenzien
MA23581A1 (fr) Agent pesticide synergique
DE59510955D1 (de) Offsetdruckmaschine
LV11684A (lv) Pesticidi
FI940218A0 (fi) Antiparasiittisia aineita
PT828506E (pt) Agentes endoparasiticidas
FI97864B (fi) Sprinkleri
DK0831697T3 (da) Mikrobicide midler
BR9509374A (pt) Composições herbicidas
BR9508191A (pt) Composição herbicida
BR9607487A (pt) Composição herbicida
NO304843B1 (no) Nedfallsr°r
NO965605D0 (no) Antibakterielle midler
DE69709700D1 (de) Kontrastmittel
KR960018679U (ko) 입간판
ATE249247T1 (de) Kontrastmittel